Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-22T07:27:35.694Z Has data issue: false hasContentIssue false
  • English
  • Français

Glutamate Modulation in Mood and Anxiety Disorders: Toward a Rational Pharmacology?

Published online by Cambridge University Press:  07 November 2014

Sanjay J. Mathew
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
CNS Spectrums , Volume 10 , Issue 10 , October 2005 , pp. 806 - 807
Copyright
Copyright © Cambridge University Press 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Moghaddam, B, Wolf, ME, eds. Glutamate and disorders of cognition and motivation. Ann N Y Acad Sci. 2003;1003:xiv.Google Scholar
2.Peterson, BS. Conceptual, methodological, and statistical challenges in brain imaging studies of developmentally based psychopathologies. Dev Psychopathol. 2003;15:811–832.Google Scholar
3.Walker, DL, Ressler, KJ, Lu, KT, Davis, M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002;22:2343–2351.Google Scholar
4.Rothstein, JD, Patel, S, Regan, MR, et al.Beta-lactam antibiotics offer neuroprotectiun by increasing glutamate transporter expression. Nature. 2005;433:73–77.Google Scholar